UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934


                           RHAPSODY ACQUISITION CORP.
--------------------------------------------------------------------------------
                                (Name of Issuer)

                    Common Stock, par value $0.0001 per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    762014108
--------------------------------------------------------------------------------
                                 (CUSIP Number)

Eric S. Rosenfeld                 with a copy to:   David Alan Miller, Esq.
Rhapsody Acquisition Corp.                          Graubard Miller
825 Third Avenue, 40th Floor                        405 Lexington Avenue
New York, NY 10022                                  New York, NY 10174-1901
--------------------------------------------------------------------------------

(Name, Address and Telephone Number of Person Authorized to Receive Notices and
                                 Communications)

                                  June 13, 2008
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. |_|

Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See ss.240.13d-7 for other
parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

Persons who respond to the collection of information contained in this form are
  not required to respond unless the form displays a current valid OMB control
                                    number.




--------------------------------------------------------------------------------
1    NAME OF REPORTING PERSON
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON (ENTITIES ONLY).

     Eric S. Rosenfeld
--------------------------------------------------------------------------------
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
                                                                        (a)  |_|
                                                                        (b)  |_|
--------------------------------------------------------------------------------
3    SEC USE ONLY


--------------------------------------------------------------------------------
4    SOURCE OF FUNDS (SEE INSTRUCTIONS)

     PF
--------------------------------------------------------------------------------
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
     ITEMS 2(d) OR 2(e)                                                      |_|


--------------------------------------------------------------------------------
6    CITIZENSHIP OR PLACE OF ORGANIZATION

     United States
--------------------------------------------------------------------------------
               7    SOLE VOTING POWER

                    865,000
               -----------------------------------------------------------------
  NUMBER OF    8    SHARED VOTING POWER
   SHARES
BENEFICIALLY        106,840
  OWNED BY     -----------------------------------------------------------------
    EACH       9    SOLE DISPOSITIVE POWER
  REPORTING
   PERSON           865,000
    WITH       -----------------------------------------------------------------
               10   SHARED DISPOSITIVE POWER

                    106,840
--------------------------------------------------------------------------------
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     971,840
--------------------------------------------------------------------------------
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
     (SEE INSTRUCTIONS)
                                                                             |_|

--------------------------------------------------------------------------------
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     15.4%
--------------------------------------------------------------------------------
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     IN
--------------------------------------------------------------------------------


                                        2


      This Schedule 13D is filed by Eric S. Rosenfeld ("Rosenfeld") with respect
to ownership of the common stock of Rhapsody Acquisition Corp., a Delaware
corporation (the "Issuer").

      The percentages of beneficial ownership reflected in this Schedule 13D are
based upon 6,300,000 shares outstanding as set forth in the Issuer's Current
Report on Form 10-KSB for the fiscal year ended March 31, 2008, filed on June 2,
2008.

Item 1.           Security and Issuer

      The class of equity securities to which this Statement on Schedule 13D
relates is the common stock, par value $0.0001 per share (the "Common Stock"),
of the Issuer. The principal executive office of the Issuer is 825 Third Avenue,
40th Floor, New York, New York 10022.

Item 2.           Identity and Background.

      This Statement is being filed by Rosenfeld. The business address of
Rosenfeld is 825 Third Avenue, 40th Floor, New York, New York 10022. Rosenfeld
has been chairman of the board, chief executive officer and president of the
Issuer since its inception. The Issuer was formed to serve as a vehicle to
effect a business combination with an operating business. Since its formation
and initial public offering, the Issuer has been searching for prospective
target businesses to acquire. On February 19, 2008, the Issuer signed a
definitive merger agreement with Primoris Corporation.

      During the past five years, Rosenfeld has not been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors).

      During the past five years, Rosenfeld has not been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction and as
a result of such proceeding was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violation with
respect to such laws.

      Rosenfeld is a citizen of the United States.

Item 3.           Source and Amount of Funds or Other Consideration.

      In April 2006, in connection with the Issuer's formation, Rosenfeld
purchased 765,000 shares of Common Stock at a purchase price of approximately
$0.0222 per share. Rosenfeld used his personal funds to purchase such shares at
that time. Additionally, the Rosenfeld 1991 Children's Trust, a trust
established for Rosenfeld's children of which Rosenfeld's wife is the sole
trustee, purchased an aggregate of 106,840 shares of Common Stock at a purchase
price of approximately $0.0222 per share.

      In October 2006, Rosenfeld purchased warrants ("Warrants") to purchase an
aggregate of 863,636 shares of the Issuer's Common Stock for an aggregate
purchase price of $950,000. The Warrants have an exercise price of $5.00 per
share and will become exercisable upon the completion of a business combination.
The Warrants expire on October 2, 2010.

      On June 13, 2008, Rosenfeld purchased 100,000 shares of Common Stock at a
purchase price of $8.22 per share.

      Rosenfeld used his personal funds to purchase the foregoing securities.


                                        3


Item 4.           Purpose of Transaction

      Rosenfeld acquired the Common Stock for investment purposes.

      (i) Rosenfeld may acquire additional securities from time to time in the
open market or in private transactions. Additionally, Rosenfeld holds Warrants
to purchase an aggregate of 863,636 shares of the Issuer's Common Stock. The
Warrants have an exercise price of $5.00 per share and will become exercisable
upon the completion of a business combination. The Warrants expire on October 2,
2010.

      (ii) At the date of this Statement, Rosenfeld, except as set forth in this
Statement, and consistent with Rosenfeld's positions with the Issuer, has no
plans or proposals which would result in:

            (a) The acquisition by any person of additional securities of the
      Issuer, or the disposition of securities of the Issuer;

            (b) An extraordinary corporate transaction, such as a merger,
      reorganization or liquidation, involving the Issuer or any of its
      subsidiaries;

            (c) A sale or transfer of a material amount of assets of the Issuer
      or any of its subsidiaries;

            (d) Any change in the present board of directors or management of
      the Issuer, including any plans or proposals to change the number or term
      of the board of directors or management of the Issuer;

            (e) Any material change in the present capitalization or dividend
      policy of the Issuer;

            (f) Any other material change in the Issuer's business or corporate
      structure;

            (g) Changes in the Issuer's charter, bylaws or instruments
      corresponding thereto or other actions which ay impede the acquisition of
      control of the Issuer by any person;

            (h) Causing a class of securities of the Issuer to be delisted from
      a national securities exchange or to cease to be authorized to be quoted
      in an inter-dealer quotation system of a registered national securities
      association;

            (i) A class of equity securities of the issuer becoming eligible for
      termination of registration pursuant to Section 12(g)(4) of the Act; or

            (j) Any action similar to any of those actions enumerated above.

Item 5.           Interest in Securities of the Issuer.

      Rosenfeld beneficially owns 971,840 shares of the Issuer's Common Stock.
Rosenfeld has sole dispositive and voting power over 865,000 shares of Common
Stock and has shared dispositive and voting power over 106,840 shares of Common
Stock, representing shares of common stock held by the Rosenfeld 1991 Children's
Trust, a trust of which Rosenfeld's wife is the sole trustee. Rosenfeld
beneficially owns 15.4% of the Issuer's outstanding shares of Common Stock. The
foregoing does not include 863,636 shares of Common Stock issuable upon exercise
of Warrants held by Rosenfeld that are not currently exercisable and may not
become exercisable within 60 days.

      During the past 60 days, Rosenfeld effected the purchases on June 13, 2008
as described in Item 3 above.

Item 6.           Contracts, Arrangements, Understandings or Relationships With
                  Respect to Securities of the Issuer.

      None.

Item 7.           Material to be Filed as Exhibits.

      None.


                                        4


                                   SIGNATURES


      After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


Dated: June 25, 2008



                                                     /s/ Eric S. Rosenfeld
                                                     ---------------------
                                                     Eric S. Rosenfeld


                                        5